StemRegenin1 (SR1) is an antagonist of AhR demonstrating unique ability to generate natural killer cells having efficient interferon-γ production capability and cytolytic activity against AML and multiple myeloma cells. The gene discussed is AHR; the disease is acute myeloid leukemia.